Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
States Sue to Block H-1B Visa Fee The attorneys general of 20 states, led by California and Massachusetts, filed a federal lawsuit aimed at blocking the Trump administration’s new $100,000 fee...
Florida House Speaker Daniel Perez (R) unveiled a two-bill healthcare package aimed at aligning the state with President Trump’s new federal framework. HB 693 would tighten eligibility for Medicaid...
President Donald Trump has waded into one of the most pressing and prevalent issues in state capitols these days: regulating artificial intelligence. In early December, the president said on his Truth...
Federal Government’s Penny Pinching Could Spur States to Set New Rounding Rules for Cash Sales Retailers are pushing for national rules to allow businesses to round cash sales to the nearest nickel...
OH Gov Vetoes Bill to Expand Youth Work Hours Ohio Gov. Mike DeWine (R) vetoed a bill ( SB 50 ) that would have allowed 14- and 15-year-olds to work until 9 p.m. year-round. DeWine said in his veto message...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies expiring at the end of this year. Since states don’t have the resources to replace all that federal funding, health insurance premiums are likely to soar next year. (PLURIBUS NEWS)
New Hampshire Gov. Kelly Ayotte (R) signed a bill (HB 701) allowing patients to try experimental health treatments for rare diseases. The measure expands on a law enacted by the state in 2016. (WMUR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.